Month: May 2023

It’s a fact. America’s population is aging. Lifespans are increasing due to medical and lifestyle advances, so a healthy 70-year old man’s life expectancy may be greater than his father’s was at the same age. Here’s another fact: prostate cancer (PCa), the most common tumor cancer in men, is considered a disease of aging. The keep reading

Prostate cancer (PCa) is the most common non-skin cancer in men, and it’s one of the most curable if it’s detected early. In addition, the American Cancer Society points out, “Catching cancer early often allows for more treatment options.” This is definitely true for PCa, since the number of available treatment methods has grown in keep reading

People are talking about the latest news: there may be a connection between having a vasectomy and being at risk for prostate cancer. A study from the Harvard School of Public Health has raised a red flag in the minds of men who already had vasectomies, and those who are considering them... keep reading

Is there a connection between prostatitis and prostate cancer (PCa)? No one knows for sure because there’s evidence on both sides of the question. What is prostatitis? Prostatitis is an inflammation of the prostate gland (think of swelling and irritation). Roughly 6-10% of men will have prostatitis at some time. There are two general types: keep reading

Since the early 1990s, prostate needle biopsy using transrectal ultrasound (TRUS) guidance has been the reigning method for diagnosing prostate cancer. Compared to prior biopsy methods, it was a relative walk in the park. Transrectal ultrasound not only made prostate biopsy less invasive, it also had... keep reading

Karam, et al. (2023) did an incredible job of comparing seven popular dietary programs for cardiovascular health, and guess which one came out on top? The Mediterranean diet, of course. Their objective was to look at the impact of diet on all-cause mortality, cardiovascular mortality, and specific cardiovascular events... keep reading

It’s frustrating when I hear focal therapy described as experimental. There are still many naysayers among urologists and oncologists who insist that focal therapy has not yet demonstrated its merits. To address their skepticism, I turn to international expert Professor Mark Emberton of University College London. Mr. Emberton (see explanation below for why British surgeons keep reading